A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

A blood test may rapidly distinguish brain bleeds from clot-caused strokes, even before people with stroke symptoms reach the ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Unable to speak because of a brain disorder known as spasmodic dysphonia, Susan O'Sullivan signed up for a clinical trial, ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

The Belarusian State Medical University (BSMU) and the National Medical Centre at Uzbekistan’s Health Ministry have discussed vectors of ...

Peter Fenwick and Caspar Throughout his career, neuropsychiatrist Peter Fenwick sought explanations for human experiences and consciousness that went beyond conventional models of brain function. He ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Researchers using intracranial electroencephalogram (EEG) recordings from deep within the brain found that meditation led to changes in activity in the amygdala and hippocampus, key brain regions ...